Trek Bicycle Recalls 900,000 Bicycles due to Lever Defect

Trek Bicycle

Trek Bicycle, based in Waterloo, Wisconsin, will recall 900,000 bicycles equipped with front disc brakes because of a defect in the front quick release lever that opens past 180 degrees.  When the front quick release lever is left open or improperly adjusted, the quick release can come into contact with the front disc brake assembly, causing the front wheel to come to a sudden stop or separate from the bicycle.

The recall involves all models of Trek bicycles from model years 2000 through 2015 equipped with front disc brakes and a black or silver quick release lever on the front wheel hub that open a full 180 degrees.  Bicycles with front quick release levers that do not open a full 180 degrees from the closed position, are not included in this recall at this time.  There have been three incidents reported from this defect, and all have resulted in injuries.  The incidents resulted in one person being rendered a quadriplegic, facial injuries to another, and finally, an incident that resulted in a fractured wrist for the rider.  Trek advises that if you are unsure whether your bicycle has this combination, please take it to your local Trek retailer for a free inspection.  The bicycles were sold from September 1999 to April 2015.

 

Quick release lever caught in front disc

Quick release lever caught in front disc

Consumers should stop using the bicycles immediately and contact an authorized Trek retailer for free installation of a new quick release on the front wheel.  Trek will provide each owner who participates in the recall with a $20 coupon that is redeemable by December 31, 2015 toward any Bontrager merchandise.  The coupon has no cash value.

Click here to the full defect notice:  Trek Safety Recall

The lawyers at The Brandi Law Firm have represented a number of people involving defective consumer products and people injured due to design defects in automobiles and consumer products.  If you or a loved one has been injured in an auto crash, our attorneys at The Brandi Law Firm are available to consult with you.  Please contact our office at 800-481-1615 or email us.

Trademark Notice

Trek Bicycle is a registered trademark of Trek Bicycle Corporation.  The use of this trademark is solely for product identification and informational purposes.  Trek Bicycle Corporation is not affiliated with this website, and Trek Bicycle Corporation has no affiliation with The Brandi Law Firm.  Nothing on this site has been authorized or approved by Trek Bicycle Corporation.

, , , , ,

Leave a comment

GM Recalls 87,063 Chevrolet Malibu Vehicles due to Roof Panel Defect

2015 Chevrolet Malibu

2015 Chevrolet Malibu

Due to a software defect in the slide or tilt function for the roof panel, General Motors will recall 87,063 Chevrolet Malibu vehicles that were manufactured from October 24, 2011 to March 5, 2015.  The models include the 2013, 2014, and 2015 Malibus.  These vehicles fail to comply with the requirements of FMVSS No. 18, which relate to Power-Operated Window, Partition, and Roof Panel Systems.  In the affected vehicles, the Slide or Tilt switch for the roof panel may not be adequately recessed to prevent the switch from inadvertently being pressed.  Thus, the roof panel switch may inadvertently be pressed and the roof panel may auto close unexpectedly.

GM will notify owners, and dealers will update the Body Control Module (BCM) software to remove auto-close feature for certain switch positions, free of charge.  The manufacturer has not yet provided a notification schedule.  Owners may contact Chevrolet customer service at 1-800-222-1020. GM’s number for this recall is 15176.

Americans rely on manufacturers to provide a safe well-designed product.  Sadly, that is not often the case.  The Auto Defect Attorneys at The Brandi Law Firm have successfully represented many people injured from defective autos such as Toyotas, Fords, Chryslers, Hondas, GM, and their component parts. Additionally, we have successfully represented people injured by defective helmets, bicycles, motorcycles, fuel pumps, brakes, car seats, seat belts, air bags, table saws, pumps, industrial machinery used in the workplace, barbeques, heating systems, and numerous other household and industrial products.

Often times, people involved in accidents do not examine the issues of defective product design, the risks inherent in the design, feasible alternatives, and appropriate warnings.  In a car accident, we examine whether the car was truly crashworthy – does it contain the appropriate crash protection.  In accidents where someone strikes a guardrail, people often do not consider the guardrail may be unsafe, installed improperly, or whether there is a contributing factor in the roadway design leading to a dangerous condition.  We have represented a number of people seriously injured in these types of accidents involving dangerous conditions of roads and crashworthy vehicles.  If you or a loved one has been injured in an auto crash, our attorneys at The Brandi Law Firm are available to consult with you.  Please contact our office at 800-481-1615 or email us.

Trademark Notice

GM is a registered trademark of General Motors Company.  The use of this trademark is solely for product identification and informational purposes.  General Motors Company is not affiliated with this website, and General Motors Company has no affiliation with the Brandi Law Firm.  Nothing on this site has been authorized or approved by General Motors Company.

 

, , , , , ,

Leave a comment

Graco Fined $10 Million in Civil Penalties due to Untimely Notification of Defect

graco recall buckle

On March 20, 2015, the U.S. Transportation announced that Graco Children’s Products had been fined $10 million after the company failed to provide timely notification of a defect in their car seats regarding a defective buckle that resulted in more than 4 million car seats recalled.  The defect in the car seat stems from the unlatching mechanism in the harness buckle.  The buckle becomes stuck in a latched condition so that it cannot be opened by depressing the buckle’s release button.

Click here to read the full article: U.S. Transportation Secretary Foxx Announces $10 Million Civil Penalty Against Child Car Seat Manufacturer

Graco was fined $3 million in civil penalties for immediately payment, and then an addition $7 million is due from the company in 5 years unless Graco spends at least the same amount on new steps to improve child safety.  The company will be required to provide certification to the U.S. Transportation from an independent, third-party that it has met its cost obligations regarding safety.  If Graco fails to meet those requirements, it must pay the balance of the $10 million civil penalty.

Graco must now commit at least $7 million in safety performance requirements, which may include:

  • Improving its assessment and identification of potential safety defects.
  • Creating a scientifically tested program to increase effectiveness of child seat registration programs.
  • Revising its procedures for addressing consumer safety complaints and speed the recall of defective products.
  • Launching a campaign to disseminate safety messages to parents and caregivers by producing media products to incorporate in child safety campaigns.

Americans rely on manufacturers to provide a safe well-designed product.  Sadly, that is not often the case.  The Auto Defect Attorneys at The Brandi Law Firm have successfully represented many people injured from defective autos such as Toyotas, Fords, Chryslers, Hondas, GM, and their component parts. Additionally, we have successfully represented people injured by defective helmets, bicycles, motorcycles, fuel pumps, brakes, car seats, seat belts, air bags, table saws, pumps, industrial machinery used in the workplace, barbeques, heating systems, and numerous other household and industrial products.

Often times, people involved in accidents do not examine the issues of defective product design, the risks inherent in the design, feasible alternatives, and appropriate warnings.  In a car accident, we examine whether the car was truly crashworthy – does it contain the appropriate crash protection.  In accidents where someone strikes a guardrail, people often do not consider the guardrail may be unsafe, installed improperly, or whether there is a contributing factor in the roadway design leading to a dangerous condition.  We have represented a number of people seriously injured in these types of accidents involving dangerous conditions of roads and crashworthy vehicles.  If you or a loved one has been injured in an auto crash, our attorneys at The Brandi Law Firm are available to consult with you.  Please contact our office at 800-481-1615 or email us.

Trademark Notice

Graco is a registered trademark of Graco Children’s Products Inc.  The use of this trademark is solely for product identification and informational purposes.  Graco Children’s Products Inc. is not affiliated with this website, and Graco Children’s Products Inc. has no affiliation with The Brandi Law Firm.  Nothing on this site has been authorized or approved by Graco Children’s Products Inc.

, , , , , ,

Leave a comment

Toyota Recalls 110,085 Newer Model Vehicles Due to Power Steering Failure

2015 Toyota Camry

2015 Toyota Camry

Toyota will recall 110,085 newer model Toyota Camrys, Highlanders, and RAV4s due a manufacturing processing error of the electric power steering component.  The subject vehicles are equipped with an electric power steering (EPS) system consisting of an EPS electronic control unit (ECU) and a steering column assembly with an attached power steering motor, rotation angle sensor, and torque sensor.   During the manufacturing processing, a component of the electric power steering (EPS) electronic control unit (ECU) may have been damaged.  This is a result of a manufacturing error.  Over time, this defect may result in failure of the electric power steering system.  During driving, there could be an unexpected loss of power steering.

The vehicles affected by this recall include the 2015 Camry, the 2015 Highlander, and 2014-2015 RAV4.  These vehicles were manufactured between August 2014 to November 2014.

Click here to read about the full recall:  Toyota Electric Power Steering Failure

Toyota will notify owners, and dealers will inspect the serial number of the EPS ECU or steering column assembly.  If the number is within the affected range, the EPS ECU will be replaced, free of charge.  The recall is expected to begin in April 2015.  Owners may contact Toyota customer service at 1-800-331-4331.

Americans rely on manufacturers to provide a safe well-designed product.  Sadly, that is not often the case.  The Auto Defect Attorneys at The Brandi Law Firm have successfully represented many people injured from defective autos such as Toyotas, Fords, Chryslers, Hondas, GM, and their component parts. Additionally, we have successfully represented people injured by defective helmets, bicycles, motorcycles, fuel pumps, brakes, car seats, seat belts, air bags, table saws, pumps, industrial machinery used in the workplace, barbeques, heating systems, and numerous other household and industrial products.

Often times, people involved in accidents do not examine the issues of defective product design, the risks inherent in the design, feasible alternatives, and appropriate warnings. In a car accident, we examine whether the car was truly crashworthy – does it contain the appropriate crash protection. In accidents where someone strikes a guardrail, people often do not consider the guardrail may be unsafe, installed improperly, or whether there is a contributing factor in the roadway design leading to a dangerous condition. We have represented a number of people seriously injured in these types of accidents involving dangerous conditions of roads and crashworthy vehicles.  If you or a loved one has been injured in an auto crash, our attorneys at The Brandi Law Firm are available to consult with you.  Please contact our office at 800-481-1615 or email us.

Trademark Notice

Toyota is a registered trademark of Toyota Motor Corporation.  The use of this trademark is solely for product identification and informational purposes.  Toyota Motor Corporation is not affiliated with this website, and Toyota Motor Corporation has no affiliation with The Brandi Law Firm.  Nothing on this site has been authorized or approved by Toyota Motor Corporation.

, , , , , ,

Leave a comment

Johnson and Johnson Again Leads Big Pharma in 2014 Revenues

J&J, who has seemingly survived the DePuy wars and is now facing down 22,000 vaginal mesh suits after losing mesh verdicts for its Ethicon product again leads the way in profits for Big Pharma in 2014, according to Tracy Staton writing in Fierce Pharma.

Click here to read the full article: The Top 15 Pharma Companies by 2014 Revenue

The top 15 list contains all of the traditional Big Pharma players: J&J, Novartis, Roche, Pfizer, Sanofi, Merck, GSK, AstraZeneca, Bayer, AbbVie, Lilly and Bristol-Myers Squibb, as well as some relative new comers: Gilead Sciences, Teva, and Amgen.  These 15 companies amassed 2014 sales of just under $527 billion.  J&J’s revenues increased by slightly more than $3 billion (4%), Roche grew by $1.3 billion (2.7%), Amgen was up by roughly $1.4 billion (7%), Bayer rose by $1.3 billion (5%), and AbbVie grew by almost $1.2 billion (5.8%).

J&J’s $74 billion was led by prescription drugs, which  brought in $32.4 billion for J&J last year, making pharma the biggest of its divisions.

CEO Alex Gorsky

CEO Alex Gorsky

CEO Alex Gorsky is well compensated for his leadership.  According to salary.com Alex Gorsky in 2013 made $15,171,960 in total compensation.  Of this total $1,453,846 was received as a salary, $4,867,361 was received as a bonus, $2,669,999 was received in stock options, $5,988,975 was awarded as stock and $191,779 came from other types of compensation.  This information is according to proxy statements filed for the 2013 fiscal year.

J& J’s litigation in DePuy is well documented as is its efforts with vaginal mesh.

Contact Our Experienced San Francisco Drug Recall Lawyers Today

At The Brandi Law Firm, we help people throughout the country who have been harmed because of a defective drug or medical device such as Actos (Takata), Fosamax (Merck), DePuy (Johnson & Johnson), Lipitor (Pfizer), Yaz (Bayer) and Vaginal Mesh (Johnson & Johnson).  Instead of treating all victims of defective drugs and medical devices the same we take a different, more personalized approach with a team of experienced defective drug attorneys and paralegals working for every client.  Our goal is to provide you with information about your legal options and to help you pursue compensation and holding these drug companies responsible for their dangerous actions.  Please contact The Brandi Law Firm today (1-800-481-1615 or email us) to talk with the experienced San Francisco defective drug attorneys.

Trademark Notice

Johnson & Johnson is a registered trademark of Johnson & Johnson Inc.  The use of this trademark is solely for product identification and informational purposes.  Johnson & Johnson Inc. is not affiliated with this website, and Johnson & Johnson Inc. has no affiliation with The Brandi Law Firm.  Nothing on this site has been authorized or approved by Johnson & Johnson Inc.

, , , , , , , ,

Leave a comment

Big PHARMA Spends $4.58 Billion in Direct to Consumer Ads in 2014

Whenever you watch the news, or a sporting event, does it ever seem like there are a lot of ads for drugs? For that special moment there are Cialis and Viagra and a host of other things that nice looking people suffering various maladies suddenly get better in a 30 to 60 second span while you are extolled to “Ask your Doctor about…”, while the fastest talking person you have ever heard rockets through risks and side effects.

Eli Lilly spent $272 million on ads for Cialis in 2014 while Pfizer spent $232 million on Viagra. Past years total spending, include 2013, was $3.83 billion and in 2012 $3.47 billion.

But it is not quite the $4.17 billion spent in 2010 or the $5.4 billion spent in 2006.

Pfizer, who led in spending in 2013, again led all drug companies spending an astounding $1.4 billion on ads in 2014.  In fact, Pfizer ranked among the top 10 of all advertisers, ahead of Toyota, Chrysler, Verizon, but behind L’Oreal.

According to a bulletin of the World Health Organization, “Direct-to-consumer advertising of drugs has been legal in the USA since 1985, but only really took off in 1997 when the Food and Drug Administration (FDA) eased up on a rule obliging companies to offer a detailed list of side-effects in their infomercials (long format television commercials).  Since then, the industry has poured money into this form of promotion, spending just under $5 billion last year alone.  The only other country in the world that allows direct-to-consumer drug ads is New Zealand, a country of just over four million people.”

Click here to read the full article: Direct-to-Consumer Advertising Under Fire 

Clearly, direct-to-consumer ads work in driving sales.  But, is a 30 to 60 second format the best way to inform a consumer of what can really happen?  But the point of the ads is to create demand and history shows it creates that and huge profits too.

At The Brandi Law Firm, we help people throughout the country who have been harmed because of a defective drug or medical device such as Actos (Takata), Fosamax (Merck), DePuy (Johnson & Johnson), Lipitor (Pfizer), Yaz (Bayer), Avandia (GSK), and Vaginal Mesh (Johnson & Johnson).  Instead of treating all victims of defective drugs and medical devices the same we take a different, more personalized approach with a team of experienced defective drug attorneys and paralegals working for every client.  Our goal is to provide you with information about your legal options and to help you pursue compensation and holding these drug companies responsible for their dangerous actions.  Please contact The Brandi Law Firm today (1-800-481-1615 or email us) to talk with the experienced San Francisco defective drug attorneys.

 

, , , , , ,

Leave a comment

Honda Expands Air Bag Recall to 104,871 Older Model Vehicles

Honda continues to expand the air bag recall that has affected millions of vehicles due to defective Takata inflator parts.  Honda will now be recalling an additional 104,871 vehicles as a result this defect.  In March 2015, Honda began matching Takata airbag inflator part numbers to individual VINs based on factory production records.  Through this process, Honda discovered that 88,549 units of the 2008 Honda Pilot should have been included in the original recall.  Additionally, Honda identified certain 2001 Accord (5,454 vehicles) and 2004 Civic (10,868 vehicles) that had not been properly identified by VIN as being produced for the US market, and is adding those vehicles to 14V351.

Click here to read the recall:  Honda Recall

The vehicles affected are:

2008 Honda Pilot

Manufactured May 3, 2007 to April 14, 2008

VINs

5FNYF18208B000011 to 5FNYF18508B057545

5FNYF283X8B000001 to 5FNYF28538B031186

2001 Honda Accord

Manufactured April 26, 2000 – August 15, 2001

VINs

1HGCG22581A000001 to 1HGCG22461A036745

3HGCG66591G700001 to 3HGCG66521G714452

2004 Honda Civic

Manufactured June 5, 2003 to August 2, 2004

VINs

JHMES95684S000001 to JHMES95664S022823

Honda will notify owners, and dealers will replace the driver side frontal air bag inflator in all affected vehicles, free of charge. The manufacturer has not yet provided a notification schedule. Owners may contact Honda customer service at 1-800-999-1009. Note: This recall is an expansion of recall 14V-351.

Americans rely on manufacturers to provide a safe well-designed product.  Sadly, that is not often the case.  The Auto Defect Attorneys at The Brandi Law Firm have successfully represented many people injured from defective autos such as Toyotas, Fords, Chryslers, Hondas, GM, and their component parts. Additionally, we have successfully represented people injured by defective helmets, bicycles, motorcycles, fuel pumps, brakes, car seats, seat belts, air bags, table saws, pumps, industrial machinery used in the workplace, barbeques, heating systems, and numerous other household and industrial products.

Often times, people involved in accidents do not examine the issues of defective product design, the risks inherent in the design, feasible alternatives, and appropriate warnings. In a car accident, we examine whether the car was truly crashworthy – does it contain the appropriate crash protection. In accidents where someone strikes a guardrail, people often do not consider the guardrail may be unsafe, installed improperly, or whether there is a contributing factor in the roadway design leading to a dangerous condition. We have represented a number of people seriously injured in these types of accidents involving dangerous conditions of roads and crashworthy vehicles.  If you or a loved one has been injured in an auto crash, our attorneys at The Brandi Law Firm are available to consult with you.  Please contact our office at 800-481-1615 or email us.

Trademark Notice

Honda is a registered trademark of Honda Motor Corporation.  The use of this trademark is solely for product identification and informational purposes.  Honda Motor Corporation is not affiliated with this website, and Honda Motor Corporation has no affiliation with The Brandi Law Firm.  Nothing on this site has been authorized or approved by Honda Motor Corporation.

, , , , , , , ,

Leave a comment

Pennsylvanian Jury Awards $3.6 Million Verdict in Actos Trial

On February 12, 2015, a Philadelphia jury awarded a $3.6 million dollar verdict, which included a $1.3 million punitive damage award, to John Kristufek, a former Pennsylvanian educator, who alleged that pharma giant Takeda Pharmaceutical Co.’s Actos diabetes drug was the cause of his bladder cancer.

Click here to read the full article: Takeda Ordered to Pay $2.3 Million in Damages to Actos User

After two days of deliberation, the jury found that Takeda failed to properly warn John Kristufek’s doctors about Actos’s cancer risks.  The jury found that Takeda showed “reckless indifference” to Kristufek’s health by hiding Actos’ risks.  The jury awarded $318,000 for his medical expenses and $2 million for pain and suffering tied to the cancer diagnosis.  Because of the reckless indifference finding, the jury awarded $1.3 million in punitive damages.

The Pennsylvania case is Kristufek v. Takeda Pharmaceuticals America Inc., Philadelphia Court of Common Pleas.  The consolidated Actos case in Louisiana is In Re Actos (Pioglitazone) Products Liability Litigation, 11-md-02299, U.S. District Court, Western District of Louisiana (Lafayette).

Actos Trial History and Lawsuits

There have been two prior verdicts for plaintiffs in California and Maryland (though those results were later overturned) and defense verdicts in Las Vegas and Chicago.  The Allen case in Louisiana was the first federal bellwether case to be tried, where the jury held Takeda responsible and ordered the big pharma giant to pay $9 billion dollars in damages.

A number of cases pending are in the coordinated California JCCP, where The Brandi Law Firm represents a number of Plaintiffs.  (Case No. JCCP 4696 Assigned to Hon. Kenneth Freeman)

If you or a loved one has had a problem with Actos or has been diagnosed with bladder cancer and took the diabetes drug Actos, you may have a claim for your injuries.  The Brandi Law Firm is a leader in nationwide pharmaceutical litigation for decades and is now representing clients who have suffered bladder cancer related to Actos use and filed suits on their behalf.  For a free consultation call us at 1-800-481-1615 or email us.

Trademark Notice

Actos is a registered trademark of Takeda Pharmaceutical Company, Ltd.  The use of this trademark is solely for product identification and informational purposes. Takeda Pharmaceutical Company, Ltd. is not affiliated with this website, and Takeda Pharmaceutical Company, Ltd. has no affiliation with The Brandi Law Firm.  Nothing on this site has been authorized or approved by

, , , , , , , , , ,

Leave a comment

Johnson & Johnson Pleads Guilty for Metal-Tainted Children’s Tylenol and Ordered to Pay $25 Million Fine

McNeil-PPC, Inc., a subsidiary of pharma giant Johnson & Johnson, pleaded guilty on March 10, 2015 for violating the federal Food, Drug and Cosmetic Act (FDCA) with regard to infants’ and children’s liquid medications, including Infants’ Tylenol, Children’s Tylenol and Children’s Motrin.  The company has pleaded guilty to a federal misdemeanor charge and will pay a $20 million fine.  Additionally, they have been ordered to pay another $5 million for allowing Infants’ Tylenol, Children’s Tylenol and Children’s Motrin products into the market that were tainted with metals.

Click here to read the full article:  J&J pleads guilty, pays $25M tied to metal-tainted Children’s Tylenol

The complaint stems when on May 1, 2009, a complaint was received by McNeil by concerned consumer regarding the presence of “black specks in the liquid on the bottom of the bottle” of Infants’ Tylenol, which originating from its Fort Washington facility in Pennsylvania.  According to FDA documents, instead of initiating an investigation into this matter, Johnson & Johnson opted to do nothing – failing to complete or initiate a CAPA.  Court records indicate that the particles were later determined to be “nickel/chromium-rich inclusions”.   These particles are not ingredients that should have been in the products taken by children throughout the world,

FDA Commissioner Margaret Hamburg said:  “Drug quality–and especially with the medicines we give our children–is of paramount concern to the FDA. … Today’s guilty plea holds accountable those corporations who risk jeopardizing the public health by not adhering to the high standards set for drug manufacturers.”

Contact Our Experienced San Francisco Drug Recall Lawyers Today

At The Brandi Law Firm, we help people throughout the country who have been harmed because of a defective drug or medical device such as Actos, Fosamax, DePuy, and Vaginal Mesh.  Instead of treating all victims of defective drugs and medical devices the same we take a different, more personalized approach with a team of experienced defective drug attorneys and paralegals working for every client.  Our goal is to provide you with information about your legal options and to help you pursue compensation and holding these drug companies responsible for their dangerous actions.  Please contact The Brandi Law Firm today (1-800-481-1615 or email us) to talk with the experienced San Francisco defective drug attorneys.

Trademark Notice

Johnson & Johnson is a registered trademark of Johnson & Johnson Inc.  The use of this trademark is solely for product identification and informational purposes.  Johnson & Johnson Inc. is not affiliated with this website, and Johnson & Johnson Inc. has no affiliation with The Brandi Law Firm.  Nothing on this site has been authorized or approved by Johnson & Johnson Inc.

, , , , , , , , ,

Leave a comment

Nissan Recalls 625,000 Altimas Due to Latch Defect

2015 Nissan Altima

2015 Nissan Altima

Nissan has announced that it will recall 625,000 Nissan Altima vehicles due to a hood latch defect.  This recall is an expansion of an earlier recall that occurred in September 2014 when  Nissan recalled the 2013 model year Altima vehicles manufactured from March 6, 2012 to February 28, 2013.  Originally, Nissan recalled 220,423 with this issue.

The defect stems from the secondary hood latch of the vehicle.  In the affected vehicles, the secondary hood latch may bind and remain in the unlocked position even while the hood is closed.  The reason for the problem is interference between the hood inner panel and the secondary latch lever, in combination with debris and corrosion, causes the secondary hood latch to not lock properly.  If the primary latch is inadvertently released and the secondary latch is not engaged, the hood of the vehicle could unexpectedly open while driving.  These affected vehicles include the 2013, the 2014, and the 2015 Nissan Altimas.  They were manufactured from March 1, 2013 to December 31, 2014.

The manufacturer has not yet provided a remedy plan or notification schedule.  The first remedy back in September 2014 was for dealers to modify the bend angle of the hood actuation lever to eliminate potential interference with the hood inner panel.  In addition, dealers were advised to clean and lubricate the latch joint as needed.  If significant corrosion was observed, the latch assembly was to be replaced.   Owners should contact Nissan customer service at 1-800-647-7261.  Note:  This recall is an expansion of Recall 14V-565.  Hopefully, Nissan will come up with a fix soon.

Americans rely on manufacturers to provide a safe well-designed product.  Sadly, that is not often the case.  The Auto Defect Attorneys at The Brandi Law Firm have successfully represented many people injured from defective autos such as Toyotas, Fords, Chryslers, Hondas, GM, and their component parts. Additionally, we have successfully represented people injured by defective helmets, bicycles, motorcycles, fuel pumps, brakes, car seats, seat belts, air bags, table saws, pumps, industrial machinery used in the workplace, barbeques, heating systems, and numerous other household and industrial products.

Often times, people involved in accidents do not examine the issues of defective product design, the risks inherent in the design, feasible alternatives, and appropriate warnings. In a car accident, we examine whether the car was truly crashworthy – does it contain the appropriate crash protection. In accidents where someone strikes a guardrail, people often do not consider the guardrail may be unsafe, installed improperly, or whether there is a contributing factor in the roadway design leading to a dangerous condition. We have represented a number of people seriously injured in these types of accidents involving dangerous conditions of roads and crashworthy vehicles.  If you or a loved one has been injured in an auto crash, our attorneys at The Brandi Law Firm are available to consult with you.  Please contact our office at 800-481-1615 or email us.

Trademark Notice

Nissan is a registered trademark of Nissan Motor Company.  The use of this trademark is solely for product identification and informational purposes.  Nissan Motor Company is not affiliated with this website, and Nissan Motor Company has no affiliation with The Brandi Law Firm.  Nothing on this site has been authorized or approved by Nissan Motor Company.

 

, , , , , , ,

Leave a comment

Follow

Get every new post delivered to your Inbox.

Join 181 other followers